Chularat Hospital is still a buy for Thanachart Securities, citing its business strategy of gearing toward high-intensity healthcare that enhances earnings, says the brokerage’s analyst Siriporn Arunothai in a research report. It just bought a 100% stake in Century Care Store Rehabilitation Center and Residence, and plans to add stroke, cancer, advanced wound care and hyperbaric oxygen therapy centers at its new Chularat Medical Center, the analyst notes. Its 2H earnings should grow 25%, thanks to drivers such as improving Thai and foreign patient flows, the analyst adds. However, the brokerage trims its target price to THB3.80 from THB4.30 to partly reflect the hospital operator’s weak 1Q results. Shares last quoted at THB3.12. ([email protected])
Read the full article here
